Tag: ADC Conjugation

Over the years, researchers and scientists have been on the lookout to find effective ways to treat various types of oncological disorders. This is because one of the approaches, such as chemotherapy, results in killing of both healthy and cancerous cells. Therefore, an innovative approach that can kill the targeted cell while minimizing toxicity was

Last week, I wrote an article on the key innovators in ADC therapeutics space, Technological highlighting the key winners at the 6th World ADC Awards. One of the winners, that has really impressed several drug developers in this space, is Zymeworks. The company has its proprietary conjugation Technological platform, ZymeLink™, which offers site-specificity and customization